Abstract
The aim — to study the ciprofloxacin effectiveness in the treatment and prevention of purulent complications in patients with acute surgical pathology of the digestive system.Materials and methods. 85 patients with the pathology of the hepatopancreatobiliary system, which was administered сiprofloxacin (Ciprolet) were observed in the department of laparoscopic surgery and cholelithiasis for the period from 2012 to 2017.Results and discussion. The use of ciprofloxacin in patients with hepatopancreatoduodenal disease was effective in the prevention and treatment of purulent‑septic complications. Only 3 (3.8 %) patients who had undergone surgery on the biliary tract had suppuration of the postoperative wound. There were no cases of peritonitis progression. Intestinal peristalsis was restored on average 4.10 ± 0.08 day after the operation, body temperature and leukocyte count were normalized at 5.10 ± 0.09 day.Conclusions. The use of ciprofloxacin in patients with acute surgical pathology of the hepatopancreatobiliary system and the obstruction of the bile ducts of non‑tumorous genesis complicated by purulent cholangitis and mechanical jaundice is characterized by high clinical efficacy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
